Puhe BioPharma

Suzhou Puhe Biopharma Co., Ltd., located in the Wuzhong Biomedical Industry Park, is a small-molecule innovative drug company incubated by "Shiyu Investment," a well-known pharmaceutical industry fund in China. The company focuses on the development of innovative drugs in the fields of oncology and oncology support. Adhering to the strategy of meeting differentiated clinical needs, the company adopts a multidimensional approach involving science, capital, and industrial thinking. Through market-oriented operations with balanced risks, the company drives its growth via a dual approach of "company acquisitions and product introductions" alongside "independent research and development." By fully leveraging the advantages of clinical trials in China, along with flexible production scales and lower comparative cost investments, the company actively explores commercial opportunities, integrates resources, and accelerates its industrial development. In 2022, the company was included in the Jiangsu Province Science and Technology Small and Medium-sized Enterprise Database.